131 related articles for article (PubMed ID: 12419481)
1. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
Haffner SM
Am J Cardiol; 2002 Oct; 90(8A):55i-61i. PubMed ID: 12419481
[TBL] [Abstract][Full Text] [Related]
2. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
3. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
Kwiterovich PO
Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population.
Erbey JR; Robbins D; Forrest KY; Orchard TJ
Metabolism; 1999 Apr; 48(4):531-4. PubMed ID: 10206450
[TBL] [Abstract][Full Text] [Related]
7. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus.
Fukushima H; Sugiyama S; Honda O; Koide S; Nakamura S; Sakamoto T; Yoshimura M; Ogawa H; Fujioka D; Kugiyama K
J Am Coll Cardiol; 2004 Jun; 43(12):2219-24. PubMed ID: 15193683
[TBL] [Abstract][Full Text] [Related]
9. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
[TBL] [Abstract][Full Text] [Related]
10. Diabetic dyslipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
[TBL] [Abstract][Full Text] [Related]
11. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
[TBL] [Abstract][Full Text] [Related]
12. Management of dyslipidemia in adults with diabetes.
Haffner SM
Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
[TBL] [Abstract][Full Text] [Related]
13. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
Quispe R; Martin SS; Jones SR
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
[TBL] [Abstract][Full Text] [Related]
14. Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.
Huang YC; Chang PY; Hwang JS; Ning HC
Biomed J; 2014; 37(6):375-9. PubMed ID: 25179702
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
Brunzell JD; Ayyobi AF
Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862
[TBL] [Abstract][Full Text] [Related]
17. The mixed benefit of low lipoprotein(a) in type 2 diabetes.
Hermans MP; Ahn SA; Rousseau MF
Lipids Health Dis; 2017 Sep; 16(1):171. PubMed ID: 28899393
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride as a risk factor for coronary artery disease.
Gotto AM
Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.
Drexel H; Aczel S; Marte T; Vonbank A; Saely CH
Atherosclerosis; 2010 Feb; 208(2):484-9. PubMed ID: 19748621
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, inflammation, and the prediabetic state.
Haffner SM
Am J Cardiol; 2003 Aug; 92(4A):18J-26J. PubMed ID: 12957323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
